Clinical Trials Logo

Heart Diseases clinical trials

View clinical trials related to Heart Diseases.

Filter by:

NCT ID: NCT05452356 Not yet recruiting - Clinical trials for Cardiovascular Diseases

Testing VIRTUES Patient Care Sets in Cardiac Patients (VIRTUES Cardiac Care)

VIRTUES-CC
Start date: August 2023
Phase:
Study type: Observational

Patients with various cardiac conditions (such as those who experience a heart attack) are increasing in Canada and are in need of appropriate cardiac rehabilitation and care. Many patients do not have access to local in-person cardiac clinics, particularly in rural regions of Canada. A user-friendly digital application with accessible educational resources and recommendations based on the most up to date clinical practice guidelines can help mitigate these issues. VIRTUES is a digital healthcare application that targets 11 modifiable modules as follows: 1. antithrombotic management 2. lipid management 3. rate and rhythm control for atrial fibrillation 4. heart failure care 5. post myocardial infarction care 6. blood sugar management 7. blood pressure management 8. physical activity 9. healthy eating 10. smoking cessation 11. alcohol reduction Of the 11 total modules, the first 7 listed provide recommendations in VIRTUES. The remaining 4 (physical activity, healthy eating, smoking cessation and alcohol reduction) consist of simple referrals to existing recommendations (i.e., for healthy eating and physical exercise) and referrals to existing local programs (i.e., for smoking cessation and alcohol reduction). Thus, in this cohort study, the investigators will test the primary 7 modules with 200 patients per module for approximately one month each in order to obtain feedback on the usability of each module. The investigators will also conduct virtual focus group discussions to obtain open ended feedback on the application. This study will provide valuable feedback, which will be used to improve and adapt the VIRTUES application.

NCT ID: NCT05444452 Recruiting - Clinical trials for Ischemic Heart Disease

GENOSS Coronary Stent Clinical Trial

Start date: April 24, 2022
Phase: N/A
Study type: Interventional

This study aims to evaluate the efficacy and safety of abluminal biodegradable polymer ultrathin sirolimus-eluting stent (Genoss stent) as compared with a durable-polymer everolimus-eluting stent (Xience stent) in patients with coronary artery disease.

NCT ID: NCT05442385 Not yet recruiting - Cardiac Disease Clinical Trials

Indication of Admission , Treatment and Outcomes of Cardiac Patients in PICU

Start date: August 1, 2022
Phase:
Study type: Observational

Aim of the work: To describe the clinical patterns criteria of infants and children with cardiac disease admitted to PICU and their outcome.

NCT ID: NCT05442203 Recruiting - Atrial Fibrillation Clinical Trials

Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease

ECG-AID
Start date: September 7, 2022
Phase: N/A
Study type: Interventional

Atrial fibrillation is an abnormal beating of the heart that can lead to stroke or heart failure. Structural heart diseases are conditions that affect the heart valves or heart muscle and can cause permanent heart damage if left untreated. Sometimes people have atrial fibrillation or structural heart disease and do not know it. The purpose of this study is to evaluate two devices that can predict who has or may develop atrial fibrillation or structural heart disease based on the results of an electrocardiogram.

NCT ID: NCT05439369 Recruiting - Clinical trials for Valvular Heart Disease Stenosis and Regurgitation

Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease

Start date: August 1, 2022
Phase:
Study type: Observational

NPs can be used To detect subset of asymptomatic with subtle LV dysfunction for further evaluation and earlier referral for intervention and its correlation with echocardiographic finding.

NCT ID: NCT05431309 Not yet recruiting - Clinical trials for Cardiovascular Primary Prevention Strategy

Role of Screening With Coronary Computed Tomography Angiography in Primary Prevention of Coronary Heart Disease

RESPECT
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The primary objective of this study is to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy will be superior to traditional CHD prevention strategy, in reducing the future risk of CHD which included myocardial infarction, angina, cardiac death, and an emergency/urgent coronary revascularisation procedure, in a community population aged 40 to 69 years with cardiovascular risk factors but no history of cardiovascular disease.

NCT ID: NCT05430568 Not yet recruiting - Clinical trials for Valvular Heart Disease

Comparison of Post-operation Cardiopulmonary Capacity of Patients Underwent Conventional and Robot-assisted Coronary Artery Bypass Graft and Valve Replacement Surgery

Start date: August 1, 2022
Phase:
Study type: Observational

Robotic surgery is one of the most popular minimally invasive procedures for patients with coronary artery disease or valvular diseases. Studies have shown that, as compared to conventional sternotomy, patients underwent robot-assisted bypass grafting or valvuloplasty had less post-operation pain, blood transfusion volume during operation, re-operation rate, post-operation stroke rate and length of hospitalization. However, most studies focused on the comparison of complications of different procedures, and the investigation of cardiopulmonary function recovery is still lacking. Thus our study is to compare the functional outcomes between patients that undergo different surgical procedures.

NCT ID: NCT05429307 Terminated - Heart Diseases Clinical Trials

Turkish Adaptation, Validity and Reliability of Exercise Sensitivity Questionnaire

Start date: May 1, 2022
Phase:
Study type: Observational

Interoceptive complex sensations and fear beliefs resulting from cardiac risk factors or cardiovascular disease can further increase one's awareness and attention to bodily situations and cause differences in the interpretation of somatic sensations. These intraceptive somatic sensations may be the underlying factors for participation in exercise and compliance with exercise programs No Turkish questionnaire evaluating unpleasant sensations (Exercise sensitivity) was found. Exercise Sensitivity Questionnaire, which we planned to validate in our study, is a questionnaire developed by Samantha Farris et al. in 2020 to measure anxiety, exercise avoidance behavior and exercise sensitivity, which are frequently observed in individuals with heart disease.

NCT ID: NCT05425628 Not yet recruiting - Clinical trials for Cardiovascular Diseases

European FIH Study - NeoChord Transcatheter Mitral Repair System for Symptomatic Mitral Regurgitation

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Safety and performance evaluation of the NeoChord Transcatheter Mitral Repair System in patients with degenerative mitral valve regurgitation.

NCT ID: NCT05425173 Completed - Clinical trials for Congenital Heart Disease

Limbs Range of Motion Exercises Along With Chest Physical Therapy After Correction of Congenital Heart Diseases in ICU

Start date: June 20, 2022
Phase: N/A
Study type: Interventional

1. To determine the effect of limb ROMs along with chest Physical therapy on cardiopulmonary parameters after correction of congenital heart diseases in ICU 2. To determine the response of Inotropic drug in relation to Limb ROMs after Correction of Congenital heart diseases in ICU